Glancy Prongay & Murray LLP Commences Investigation on Behalf of NantHealth, Inc. Investors

LOS ANGELES--(BUSINESS WIRE)-- Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of NantHealth, Inc. (“NantHealth” or the “Company”) (NASDAQ: NH) investors concerning the Company and its officers’ possible violations of federal securities laws.

On March 6, 2017, STAT, a news organization focused on medical industry reporting, published an article alleging that NantHealth founder, Patrick Soon-Shiong, had donated $12 million to the University of Utah from three different tax-exempt entities controlled by him under a contract that required the University to funnel most of that money into NantHealth. STAT alleges that the scheme allowed the Company to inflate the number of test orders it reported to investors. On this news, the Company’s stock price fell approximately 15% during intraday trading on March 6, 2017, injuring investors.

If you purchased NantHealth securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170306006065/en/

Glancy Prongay & Murray LLP, Los Angeles/New York

Lesley Portnoy, 310-201-9150 or 888-773-9224

[email protected]

www.glancylaw.com

Source: Glancy Prongay & Murray LLP